During the past decade, Polyclinique Francheville conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique Francheville" #1 sponsor was "UNICANCER" with 9 trials, followed by "ARCAGY/ GINECO GROUP" with 6 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 6 trials sponsored, "Institut Bergonié" with 5 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique Francheville" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Aventis Pharmaceuticals" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Sanofi-Synthelabo" with 2 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique Francheville" are "Breast Cancer" (6 trials), "Colorectal Cancer" (6 trials), "Ovarian Cancer" (5 trials), "Lymphoma" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Polyclinique Francheville" in a lesser frequency.

Most popular intervention types in "Polyclinique Francheville" are "Drug" (29 trials), "Other" (4 trials), "Biological" (3 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (4 trials), "fluorouracil" (4 trials), "cyclophosphamide" (3 trials), "Anastrozole" (2 trials) and "Cetuximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique Francheville" are 22 trials for "All" genders, 15 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique Francheville". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Polyclinique Francheville, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique Francheville, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".